# Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)

> **NCT06991465** · PHASE2 · RECRUITING · sponsor: **Neil Kopek** · enrollment: 35 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **RADIATION:** Radiation Therapy
- **DRUG:** FOLFOX regimen
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT06991465
- **Lead sponsor:** Neil Kopek
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-16
- **Primary completion:** 2027-09
- **Final completion:** 2029-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-05-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06991465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06991465, "Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)". Retrieved via AI Analytics 2026-06-29 from https://api.ai-analytics.org/clinical/NCT06991465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*